# Transcutaneous Vagus Nerve Stimulation (tVNS) for Borderline Personality Disorder (tVNS-BPD)

> **NCT05892900** · NA · UNKNOWN · sponsor: **Sahlgrenska University Hospital** · enrollment: 42 (estimated)

## Conditions studied

- Borderline Personality Disorder

## Interventions

- **DEVICE:** Transcutaneous vagus nerve stimulation (tVNS)
- **DEVICE:** Sham transcutaneous vagus nerve stimulation (Sham tVNS)

## Key facts

- **NCT ID:** NCT05892900
- **Lead sponsor:** Sahlgrenska University Hospital
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2023-03-24
- **Primary completion:** 2024-12-31
- **Final completion:** 2025-12-31
- **Target enrollment:** 42 (ESTIMATED)
- **Last updated:** 2023-12-01


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05892900

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05892900, "Transcutaneous Vagus Nerve Stimulation (tVNS) for Borderline Personality Disorder (tVNS-BPD)". Retrieved via AI Analytics 2026-09-04 from https://api.ai-analytics.org/clinical/NCT05892900. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*